Hyun Kim, M.D.

(877) 460-4673
Hyun Kim, M.D.
Radiation Oncologist
Clinical Expertise
  • Gastrointestinal Cancers
  • Pancreatic Cancer
  • Rectal Cancer
  • Anal Cancer
  • Liver Cancer
  • Esophageal Cancer
  • Gynecologic Cancers
  • Endometrial Cancer
  • Cervical Cancer
  • Neuroendocrine Cancers
  • Adaptive Radiation Therapy
  • Radiopharmaceuticals / Theranostics
  • Stereotactic Body Radiation Therapy
  • Intensity Modulated Radiation Therapy
  • High Dose Rate Brachytherapy
Other Languages Spoken
Korean
Academic Appointments

Associate Professor, Department of Radiation Oncology

Director of Gastrointestinal Radiation Oncology

Director of Radiation Oncology Theranostics

Clinical Teams
Radiation Oncology
Colorectal Surgery
Gynecologic Oncology
Hepatobiliary Cancer

Hyun Kim, M.D., is an associate professor of radiation oncology, Director of GI Radiation Oncology and Director of Radiation Oncology Theranostics at City of Hope® Cancer Center Duarte. He specializes in treating patients with gastrointestinal, neuroendocrine, gynecologic and genitourinary cancers.

Dr. Kim earned his medical degree from the University of Pittsburgh School of Medicine and completed residency in radiation oncology at Thomas Jefferson University in Philadelphia, where he served as chief resident. Prior to joining City of Hope, he held several leadership roles at Washington University School of Medicine in St. Louis, including Chief of the GI Radiation Oncology and Adaptive Radiation Therapy services and co-director for the Center for Radiopharmaceuticals and Young Onset Colorectal Program.

Dr. Kim serves as Chair of the NRG Oncology Adaptive Working Group and member of pancreas and radiopharmaceutical group committees for NRG Oncology and ASTRO. He has delivered lectures internationally on his research and served as principal investigator or collaborator on multiple studies funded by the National Institutes of Health. His more than 100 peer-reviewed publications are focused on the use of novel radiation technology and cancer therapeutics as alternatives to surgery for patients with pancreatic, gastric, rectal and neuroendocrine cancers.

Location

Education & Experience

Education

  • 2006, Bachelor of Science, Molecular, Cell and Developmental Biology, University of California, Los Angeles, California
  • 2012, Doctor of Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania

Internship

  • 2013, Transitional Year, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Residency

  • 2017, Chief Resident, Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • 2017, Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Professional Experience

  • 2025-present, Associate Professor, Department of Radiation Oncology, City of Hope, Duarte, CA
  • 2025-present, Director of Radiation Oncology Theranostics, City of Hope, Duarte, CA
  • 2025-present, Director of Gastrointestinal Radiation Oncology, City of Hope, Duarte, CA
  • 2023-2025, Associate Professor, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  • 2023-2025, Chief, Adaptive Radiation Therapy Service, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  • 2022-2023, Chief, MR Clinical Service, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  • 2023-2025, Co-Director, Young Onset Colorectal Cancer Center, Siteman Cancer Center and Washington University School of Medicine, St. Louis, Missouri
  • 2023-2025, Co-Director, Center for Radiopharmaceuticals, Siteman Cancer Center and Washington University School of Medicine, St. Louis, Missouri
  • 2020-2025, Chief, Gastrointestinal Service, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  • 2019-2025, Co-Leader, Upper and Lower GI Focus Groups, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
  • 2018-2019, Interim Chief, Gastrointestinal Service, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
  • 2017-2022, Assistant Professor, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri

Publications

  • Kim H, Wuthrick E, Yock A. The NRG Adaptive Working Group: Adapting Real-Time to the Evolving Technologic Landscape in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2025 PMID: 40571368.
  • Sanford NN, Narang AK, Aguilera TA, Bassetti MF, Chuong MD, Erickson BA, Goodman KA, Herman JM, Intven M, Kilcoyne A, Kim H, Paulson E, Reyngold M, Tsai S, Tchelebi LT, Tuli R, Versteijne E, Wei AC, Wo JY, Zhang Y, Hong TS, Hall WA. NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025 PMID: 39510320.
  • D'Souza A, Kang KH, Lattin JE, Kalaghchi B, Ginn JS, Price AT, Lakomy DS, Waters MR, Schiff JP, Huang Y, Tsai R, Samson PP, DeSelm CJ, Henke LE, Forghani F, Zhao X, Morris E, Hugo GD, Zhu T, Mo A, Laugeman E, Kim H. Feasibility of Stereotactic Body Radiation Therapy for Pancreatic Tumors Abutting Organs at Risk Using Magnetic Resonance Guided Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025 PMID: 40185211.
  • Kiser K, Laugeman E, Beckert R, Kwon M, Mo A, Morris E, Barnes J, Hugo G, Robinson C, Samson P, Kim H. Minimizing bowel gas artifact in CT-guided online adaptive radiotherapy with prolonged supine positioning. Int J Radiat Oncol Biol Phys. 2025 PMID: 40185206.
  • Maughan NM, Zoberi JE, Garcia-Ramirez JL, Michalski JM, Baumann BC, Amurao M, Luechtefeld D, Marko A, Nestel A, Kim H. Handling Patient Emergencies During Radiopharmaceutical Therapy. Pract Radiat Oncol. 2024 PMID: 38354977.
  • Chuong MD, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Raphael Pfeffer M, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Jitendra Parikh P. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study. Radiother Oncol. 2024 PMID: 38135187.
  • Hassanzadeh C, Mirza K, Kalaghchi B, Fallahian F, Chin RI, Roy A, Stowe H, Low G, Pedersen K, Wise P, Glasgow S, Roach M, Henke L, Badiyan S, Mutch M, Kim H. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer. Dis Colon Rectum. 2024 PMID: 37787502.
  • Kim H, Olsen JR, Green OL, Chin R-I, Hawkins WG, Fields RC, Hammill C, Doyle MB, Chapman W, Suresh R, Tan B, Pedersen K, Jansen B, DeWees TA, Lu E, Henke LE, Badiyan S, Parikh PJ, Roach MC, Wang-Gillam A, Lim K-H. MR-guided radiation therapy with concurrent gemcitabine / nab-paclitaxel chemotherapy in inoperable pancreatic cancer: a TITE-CRM phase I trial. Int J Radiat Oncol Biol Phys. 2023 PMID: 35878713.
  • Henke LE, Fischer-Valuck BW, Rudra S, Wan L, Samson PP, Srivastava A, Gabani P, Roach MC, Zoberi I, Laugeman E, Mutic S, Robinson CG, Hugo GD, Cai B, Kim H. Prospective imaging comparison of anatomic delineation with rapid kV cone beam CT on a novel ring gantry radiotherapy device. Radiother Oncol. 2023 PMID: 36455686.
  • Chin RI, Roy A, Pedersen KS, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise P, Silviera ML, Smith RK, Suresh R, Badiyan S, Shetty AS, Henke LE, Mutch MG, Kim H. Clinical Complete Response in Patients with Rectal Adenocarcinoma Treated with Short-Course Radiation Therapy and Nonoperative Management. Int J Radiat Oncol Biol Phys. 2022 PMID: 34653579.